In ventricular myocytes, the physiological function of stromal interaction molecule 1 (STIM1), an endo/sarcoplasmic reticulum (ER/SR) Ca 2+ sensor, is unclear with respect to its cellular localization, its Ca 2+ -dependent mobilization, and its action on Ca 2+ signaling. Confocal microscopy was used to measure Ca 2+ signaling and to track the cellular movement of STIM1 with mCherry and immunofluorescence in freshly isolated adult rat ventricular myocytes and those in short-term primary culture. We found that endogenous STIM1 was expressed at low but measureable levels along the Z-disk, in a pattern of puncta and linear segments consistent with the STIM1 localizing to the junctional SR (jSR). Depleting SR Ca 2+ using thapsigargin (2-10 μM) changed neither the STIM1 distribution pattern nor its mobilization rate, evaluated by diffusion coefficient measurements using fluorescence recovery after photobleaching. Two-dimensional blue native polyacrylamide gel electrophoresis and coimmunoprecipitation showed that STIM1 in the heart exists mainly as a large protein complex, possibly a multimer, which is not altered by SR Ca 2+ depletion. Additionally, we found no store-operated Ca 2+ entry in control or STIM1 overexpressing ventricular myocytes. Nevertheless, STIM1 overexpressing cells show increased SR Ca 2+ content and increased SR Ca 2+ leak. These changes in Ca 2+ signaling in the SR appear to be due to STIM1 binding to phospholamban and thereby indirectly activating SERCA2a (Sarco/endoplasmic reticulum Ca 2+ ATPase). We conclude that STIM1 binding to phospholamban contributes to the regulation of SERCA2a activity in the steady state and rate of SR Ca 2+ leak and that these actions are independent of store-operated Ca 2+ entry, a process that is absent in normal heart cells.
STIM1 | phospholamban | store-operated calcium entry | diffusion coefficient | heart S tore-operated Ca 2+ entry (SOCE) is a cellular mechanism to ensure that sufficient levels of Ca 2+ are present in the intracellular Ca 2+ stores to enable robust signaling (1) . SOCE depends on the presence and interaction of two proteins, STIM1 (stromal interaction molecule 1) and Orai1 (a low conductance plasma/ sarcolemmal Ca 2+ channel), or their equivalents (2) (3) (4) (5) . STIM1 is an endo/sarcoplasmic reticulum (ER/SR) Ca 2+ -sensitive protein that interacts with Orai1 to activate the channel function of Orai1, a Ca 2+ selective channel, and thus permit Ca 2+ entry. SOCE is clearly present in nonexcitable cells such as T lymphocytes and some excitable cells including skeletal muscle cells (4, (6) (7) (8) (9) (10) (11) (12) (13) . STIM1 is a membrane-spanning ER/SR protein with a single transmembrane domain and a luminal Ca 2+ ( [Ca 2+ ] ER/SR )-sensing domain. When luminal Ca 2+ is low (i.e., [Ca 2+ ] ER/SR drops to less than 300 μM), then STIM1 self-aggregates and associates with Orai1 to activate it, producing a SOCE current (I SOCE ) (2, (14) (15) (16) and Ca 2+ entry (with a reversal potential E SOCE ∼ +50 mV or more) (17, 18) . Then, as [Ca 2+ ] ER/SR increases in response to the Ca 2+ influx, the process reverses. In adult skeletal muscle cells, Ca 2+ influx is normally low, and it has been suggested that SOCE is needed for maintaining an appropriate level of [Ca 2+ ] ER/SR and correct Ca 2+ signaling (6, 7, 9, 19) . In skeletal muscle, it has been hypothesized that STIM1 is prelocalized in the SR terminal cisternae (6, 20) and hence can more rapidly respond to changes in [Ca 2+ ] ER/SR . The putative importance of SOCE in skeletal muscle was further supported by the observation that the skeletal muscle dysfunction is significant in STIM1-null mice where 91% (30/33) of the animals died in the perinatal period from a skeletal myopathy (6) . Furthermore, in humans, STIM1 mutations were identified as a genetic cause of tubular aggregate myopathy (21) .
Despite the clarity of the SOCE paradigm, the canonical SOCE activation process described above does not apply to all conditions in which STIM1 and Orai1 interact. For example, in T lymphocytes, STIM1 clustering is necessary and sufficient to activate SOCE, regardless of whether [Ca 2+ ] ER/SR is low (4) . When present, the STIM1 EF hand mutation causes STIM1 oligomerization and constitutive Ca 2+ influx across the plasma membrane into cells with full Ca 2+ stores (4) . Although this is consistent with the use of STIM1 clusters and puncta to measure the activation of Orai1 (15, 16, 22, 23) , it does not necessarily reflect the state of [Ca 2+ ] ER/SR . Furthermore, several small-molecule bioactive reagents, such as 2-APB and FCCP, neither of which causes [Ca 2+ ] ER/SR depletion, induce STIM1 clustering (24) . Thus, STIM1 may have actions that are more complicated than simple [Ca 2+ ] ER/SR sensing and Orai1 signaling. Cardiomyocytes have been reported to have SOCE (8, 13, 25, 26) but are very different from many of the cells noted above that exhibit significant [Ca 2+ ] ER/SR depletion-sensitive Ca 2+ entry through the Ca 2+ -selective Orai1. Cardiac ventricular myocytes are different from the other cells in that they have large, regular, and dynamic changes in [Ca 2+ ] i and robust influx and extrusion pathways across the sarcolemmal membrane. For example, it is not unusual for investigators to measure a 10-20 nA calcium Significance Calcium ions play a central role in controlling contraction in heart muscle cells. We have investigated the function of a calcium ion signaling protein found in the heart called STIM1 (stromal interaction molecule 1) that has a known function in many other cells. We discovered, however, that in the heart STIM1 works completely differently. Instead of enabling Ca 2+ entry into the cell, STIM1 enhances the rate and amount of Ca 2+ stored and released from intracellular organelles in the steady state. Hence, more STIM1 expression increases the magnitude of the calcium signal, and this increases contraction. STIM1 thus may play an important and novel role in ventricular myocytes under physiological conditions by regulating the [Ca 2+ ] i transient and contraction. This article is a PNAS Direct Submission. 1 To whom correspondence should be addressed. Email: jlederer@umaryland.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. 1073/pnas.1423295112/-/DCSupplemental. current (I Ca,L ) in single cardiac ventricular myocytes that is readily extruded by the sarcolemmal Na + /Ca 2+ exchanger. Because of these large fluxes, adult ventricular myocytes have no "need" for SOCE and the same logic applies to neonatal cardiomyocytes. Nevertheless, reports of SOCE in neonatal cardiac myocytes are clear (10, 12, 13) . Against this background, we have attempted to determine if STIM1 is present in adult cardiomyocytes and, if so, where the protein is located, how it is mobilized, and how it may interact with other Ca 2+ signal proteins. In the work presented here, we show that STIM1 is present but that its function in heart is distinct from the canonical SOCE behavior and does not contribute to Ca 2+ influx through I SOCE . Instead we show that STIM1 binds phospholamban (PLN), an endogenous SERCA2a inhibitor in the heart (27) , and by doing so reduces the PLN-dependent inhibition of SERCA2a and thereby indirectly activates SERCA2a.
Results
Experiments were designed to investigate whether or not STIM1 is present in adult rat cardiac ventricular myocytes and, if so, what the function of STIM1 may be. The experiments were carried out using freshly isolated single ventricular myocytes from SpragueDawley rats (Materials and Methods).
STIM1 in Heart. Using rabbit polyclonal anti-STIM1 antibody (SigmaAldrich) to probe a Western blot at a distance around 84 kDa, we identified STIM1 protein from liver, from a ventricle homogenate, and from a single cardiac myocyte preparation, as shown in Fig. 1A . These bands were absent in STIM1-null mice for samples taken from single cardiac myocytes and from mouse flexor digitalis brevis (FDB) skeletal muscle (SI Appendix, Fig. S1A ). Our observations thus suggest that there is STIM1 protein in heart muscle cells. Similar results were seen with other STIM1 antibodies from BD Biosciences and Santa Cruz Biotechnology. To determine where the STIM1 in rat ventricular myocytes was located, we carried out confocal immunofluorescence imaging, as shown in Fig. 1B . The Left panel (red) shows the image of STIM1 immunofluorescence localization that resembles the distribution of the junctional SR (jSR) along the Z-disk. The position of the STIM1 within the sarcomere is confirmed by the simultaneous immunostaining of α-actinin (green). The antibody specificity is excellent, as shown in SI Appendix, Fig. S1B . To improve further the signal of the immunofluorescence localization of STIM1 in rat ventricular myocytes, we used preabsorbed antibodies (with STIM1 KO cells; Materials and Methods) to reduce nonspecific signals (Fig. 1C) . The jSR staining pattern is better seen in Fig.  1C Fig. S3 ), where STIM1-mCherry and STIM1-eYFP were cotransfected. What is clear is that the proteins appear to exist as a mixture of puncta and linear segments at the Z-disk in the presence and absence of [Ca 2+ ] SR/ER (SI Appendix, Fig. S4 ). In contrast, the fairly uniform distribution of STIM1 in the ER/SR in nonexcitable cells when [Ca 2+ ] SR/ER is high changes to a pattern of STIM1 puncta (clusters of STIM1 proteins) upon ER/SR Ca 2+ depletion due to the Tg treatment (4). These STIM1 clusters interact with the plasmalemmal Although STIM1 organization in adult cardiac ventricular myocytes seems unresponsive to [Ca 2+ ] SR/ER , the mobility of these proteins could change. To measure the STIM1 mobility, adenovirus carrying STIM1-mCherry was transfected into a primary culture of adult rat ventricular myocytes. Fig. 2 B-D shows that STIM1-mCherry is clearly expressed in rat ventricular myocytes and the spatial distribution is similar to that of WT. Fluorescence recovery after photobleaching (FRAP) experiments were performed to evaluate the mobility of STIM1-mCherry before and after [Ca 2+ ] SR/ER depletion ( Fig. 2 B, C, E, and F). Photobleaching was carried out in a 6 × 6 μm square (avoiding the nucleus) using high illumination intensity (543 nm and 488 nm laser). The fluorescence imaging during the recovery was monitored continuously at 0.5 Hz (Fig. 2E) . Our results show that STIM1-mCherry mobilizes slowly within the SR membrane. The diffusion coefficient, estimated using SimFRAP (written by Levi A. Gheber's Lab at Ben Gurion University of the Negev, Israel, Plugin in ImageJ, NIH), is ∼0.012 μm 2 /s (Fig. 2F) , much slower than in HeLa or RBL (rat basophilic leukemia) cells (22) , but similar to some membrane proteins such as water channel protein aquaporin-3 (0.0104 μm 2 /s) and delayed rectifier K + channel (Kv2.1; 0.03-0.06 μm 2 /s) (30, 31) . The diffusion coefficient of a protein may vary and depend on many factors. For example, the diffusion coefficient of BKα (Ca 2+ -activated K + channel α subunit) in vascular smooth muscle cells is ∼20 times slower than in HEK293 cells and 10,000 times slower than in bilayer (32) . Therefore, it is not surprising that the diffusion coefficient of STIM1 in ventricular myocytes is slower than in HeLa cells, particularly in light of the possible STIM1 clustering in heart cells (see results below). In the nonexcitable cells, ER Ca 2+ depletion with ionomycin clearly slowed diffusion by a factor of 2 (from 0.1 to 0.05 μm 2 /s), and this slowing was attributed to oligomerization of the STIM1 (22) . In contrast to the FRAP behavior of STIM1 in adult ventricular myocytes, in cultured neonatal cardiac myocytes the STIM1-GFP diffusion coefficient is ∼0.025 μm 2 /s (SI Appendix, Fig. S5 ), about 2 times faster than that in adult. The FRAP recovery time and STIM1 diffusion coefficients are largely unaffected in both adult and neonatal rat heart cells by [Ca 2+ ] SR/ER depletion following Tg treatment. Taken together, these results suggest that STIM1 in adult ventricular myocytes diffuses more slowly within the SR/ER structure than the STIM1 protein does in neonatal cardiac myocytes, and neither diffusion rate constants are sensitive to changes in [Ca 2+ ] SR/ER . Furthermore, the slow rate of diffusion raises the possibility that the STIM1 may be part of a large protein complex or may be oligomerized or both.
The very slow movement of STIM1 in adult heart cells may reflect the complex multimeric assembly of the STIM1 proteins, as suggested by Liou et al. (2007) (22) . Fig. 3A shows that STIM1, displayed in a native gel, forms high molecular weight (MW) protein complexes in ventricular myocytes (see band ∼550 kDa). The slow mobility of STIM1 seen in ventricular myocytes ( Fig. 2 ) is likely due in part to this high MW protein complex. There are no monomeric bands of STIM1 present in Fig. 3A , but there is a band at ∼240 kDa that is consistent with a STIM1 dimer. The composition of the dominant high MW band (∼550 kDa) is not fully known but may contain STIM1 multimers as well as STIM1 monomers or multimers associated with other proteins components. Although the dominant high MW band is large enough to be consistent with a hexameric STIM1 cluster or a smaller multimer with other proteins, additional experiments are required to determine the composition of the high MW band. Importantly, this dominant band is seen under all conditions and is significantly enhanced when STIM1-mCherry is expressed. These data suggest that a STIM1 dimer certainly exists, according to the results obtained from 2D blue native polyacrylamide gel electrophoresis (BN-PAGE) ( Fig. 3 B and C) , a finding consistent with earlier studies (22, 33) . We observe direct evidence of STIM1/STIM1-mCherry and STIM1-mCherry/STIM1-eYFP dimers in our 2D BN-PAGE and coimmunoprecipitation (co-IP) data ( Fig. 3 B-D under conditions when all three STIM1 proteins are expressed. The STIM1 clusters and the high MW bands in Fig. 3A under all conditions of [Ca 2+ ] SR/ER in adult ventricular myocytes are consistent with our observation that STIM1 is organized into both puncta and linear structures in the Z-disk, as shown in Figs. 1-3 (also see SI Appendix, Figs. S3 and S4).
Is There Evidence for SOCE in Rat Cardiac Ventricular Myocytes? That STIM1 is preassembled in puncta at the Z-disk suggests that it may be poised to interact with Orai1 (or the equivalent) to enable SOCE when [Ca 2+ ] SR/ER is very low. To test this possibility, a whole-cell patch-clamp approach was used to measure current components related to [Ca 2+ ] SR/ER depletion (see Materials and Methods for details). From a holding potential of -80 mV, the membrane potential was depolarized to +50 mV and repolarized in a linear ramp to -100 mV over 1 s, and the measured current is shown in Fig. 4 A and B. Multiple recordings were carried out with 20 s between measurements. Cells were superfused with Tyrode's solution supplemented with verapamil (10 μM) and TEA (tetraethylammonium, 10 mM) to block L-type Ca 2+ channels and K + channels. Tg (10 μM) was applied after 10-20 recordings when a stable current was obtained. A clear Tg (10 μM)-sensitive current (-218 ± 19 pA, at -80 mV, n = 14 cells) is observed, but this current is not blocked by a specific SOCE blocker (34) (BTP-2, 20 μM) nor by La 3+ (20 μM) (see green and purple lines in Fig. 4B ). Fig. 4C shows the time course of measurements of membrane current at -80 mV before and after Tg (10 μM) and the absence of any change produced by La 3+ (20 μM) . The apparent absence of any SOCE-dependent current is consistent with the observed reversal potential (E rev ,∼-15 mV) of the Tg-sensitive current that we have seen (Fig. 4  A-D) . Although the E rev shown in Fig. 4B is consistent with a nonselective ion channel and is similar to the data presented by Hulot et al. (2011) , they report it as a SOCE current (8) . Note that I SOCE , when measured in cells where SOCE has been validated, has been reported to reverse close to +50 mV or more (17, 18) , as it is highly selective for Ca 2+ . Finally, measurements of [Ca 2+ ] i under physiological conditions in the presence and absence of Tg (2 μM) shown in Fig. 4 E and F show no significant difference. Consistent with these results, neither change of diastolic membrane potential nor I Ca,L was observed in STIM1 overexpressing myocytes or in the myocytes from STIM1-null mice ( Fig. 4G and SI Appendix, Fig. S6 ). Taken together, these data, along with the undetectable Orai1 in rat ventricular myocytes (SI Appendix, Fig. S7A ), indicate that there is no SOCE in normal adult ventricular myocytes.
What Does STIM1 Do in Ventricular Myocytes? The presence of STIM1 protein as puncta and other Z-disk structures suggests the protein serves a function. A clue to a possible important role comes from adult ventricular myocytes overexpressing STIM1. These cells were observed to have a relatively large number of propagating Ca 2+ waves, compared with rare Ca 2+ waves found in control cells (Fig. 5) . The control cells expressed mCherry rather than STIM1-mCherry ( Fig. 5 A and B waves was observed in myocytes even when Orai1 is overexpressed (SI Appendix, Fig. S7 B and C).
How Does STIM1 Affect [Ca 2+ ] SR ? SR Ca 2+ content was measured in STIM1 and control cells as previously described (35) (SI Appendix, Fig. S9 ). These data show that SR Ca 2+ content is increased by 44% in STIM1 overexpressing cells compared with control. The SR Ca 2+ content in control cells was 67.5 ± 8.6 μM/L cytosol (n = 7 cells) versus 97.4 ± 10.6 μM/L cytosol in STIM1 overexpressing cells (n = 5 cells) (see Fig. 6 A and B for measurements and Fig. 6C for statistics) . That the SR Ca 2+ content is significantly different suggested to us that we should examine the [Ca 2+ ] i transients in STIM1 and control cells. higher in STIM1 overexpressing cells. The kinetics of decay of the [Ca 2+ ] i transients were notably faster in the STIM1 overexpressing rat ventricular myocytes, whereas the time to peak is not changed (Fig. 7 A and C) , suggesting faster Ca 2+ removal from cytosol. A result consistent with this observation is seen in STIM1 knockout mouse ventricular myocytes (SI Appendix, Fig.  S8 A-C) . Knocking out STIM1 reduced the peak of the [Ca 2+ ] i transient and slowed the rate of decline. This raises the question of how STIM1 can affect [Ca 2+ ] SR and the kinetics of decay of the [Ca 2+ ] i transient. The array of changes observed in the STIM1overexpressing cells is consistent with an increase in the turnover rate of SERCA. Changes in protein expression that could account for these observations include an increase in phosphorylated PLN (p-PLN) expression, an increase of SERCA2a expression, or a decrease of PLN expression. However, none of these changes is observed, as shown in Fig. 8 A and D. Nevertheless, there is an alternative possibility if STIM1 were to bind to the non-p-PLN and thereby to decrease the amount of PLN that could bind to SERCA2a and inhibit it. To investigate this possibility, interactions between STIM1 and PLN were examined in the experiments shown in Fig. 8B . When pulling down STIM1, PLN was detected in the protein complex extracted from isolated ventricular myocytes (Fig. 8B ). SERCA2a was also probed but demonstrated much less binding to STIM1 than PLN did (Fig. 8B ). In the myocytes where SR Ca 2+ was depleted by Tg (10 μM, 20 min), more PLN (∼117% of control) was detected compared with that in control myocytes ( Fig. 8 B and E) , suggesting that SR Ca 2+ depletion promotes STIM1-PLN interaction (see Discussion for a more complete explanation). However, application of isoproterenol (0.1 and 1 μM), which causes SR Ca 2+ increase and PLN phosphorylation, decreased the interaction between STIM1 and PLN ( Fig. 8 C and E) , suggesting that STIM1 favors binding to non-p-PLN. To explore this possibility, the ability of STIM1 to bind PLN and p-PLN was examined, as shown in Fig. 8 F and G and SI Appendix, Fig. S10 . In Fig. 8G , PLN was identified as a STIM1-interacting protein in a T7 phage display screen using STIM1 c terminus (STIM1c) as bait. This interaction was verified in vitro by ELISA (Fig. 8 F and G) . In SI Appendix, Fig. S10 , the relative ability of PLN to bind STIM1c was compared with the ability of p-PLN to bind STIM1c and was shown to be about 20-fold greater. To control for the possibility that the amount of p-PLN limited the sensitivity of the assay, the same test was repeated but following 10 nM treatment with isoproterenol, which increases p-PLN. As shown in SI Appendix, Fig.  S10B , the binding of PLN to STIM1c remained about 20-fold greater than p-PLN. When these data are placed in a physiological context, it would appear that when STIM1 expression increased in rodent hearts, STIM1 expression leads to SERCA2a activation. The thinking is that if the STIM1-PLN interaction were to lead to a reduction in the amount of PLN that binds to SERCA2a, then SERCA2a function and turnover rate would be increased by the presence of STIM1.
To test the hypothesis that STIM1 binds to PLN and thereby disinhibits SERCA, PLN was immunoprecipitated in control and STIM1 overexpressing myocytes (Fig. 8H) . The immunoprecipitate was then probed for SERCA2a. The relative reduction of SERCA2a detected in the immunoprecipitate in the STIM1-overexpressing cells is consistent with the hypothesis. Importantly, the amount of PLN and the amount of SERCA2a in the "input" was the same for both control and STIM1 overexpressing cells (Fig. 8 A and H) . In this scenario, the effect of STIM1 overexpression in PLN-null myocytes would be barely seen. SI Appendix, Fig. S11 indicates that absence of PLN causes increased Ca 2+ leak, similar to our finding in rat ventricular myocytes that overexpressed STIM1. STIM1 overexpression does not further increase Ca 2+ leak in PLN-null myocytes (SI Appendix, Fig. S11 ), suggesting that the presence of PLN is necessary for the effects of STIM1 to be seen, in adult rodent heart, at least. Taken together, these data suggest that STIM1 binding to PLN leads to the activation of SERCA2a. Discussion STIM1 is found in normal cardiac ventricular myocytes, but the abundance of the protein is low. Nevertheless, the STIM1 that is present is found in highly organized puncta and linear segments at the Z-disks in both normal and low [Ca 2+ ] SR . In this manner, STIM1 appears to be "frozen" in the organizational state found in developing cells with low levels of Ca 2+ in the SR/ER stores. Consistent with this is the observed mobility of STIM1 in intracellular membranes at the jSR in that it diffuses slowly whether or not there is Ca 2+ in the SR/ER lumen. The STIM1 phenotype is thus similar to what we would expect to observe in Ca 2+ -depleted SR/ER. Nevertheless, STIM1 does appear to influence SR Ca 2+ in normal ventricular myocytes. When STIM1 is overexpressed, SR Ca 2+ overload is produced and Ca 2+ instability is observed in the form of propagating Ca 2+ waves. For this to happen, it would appear to bind to the SERCA2a modulator PLN. If by doing so STIM1 could bind PLN and remove it from interacting with SERCA2a (and inhibiting function), then the net effect of this process would be to increase SR Ca 2+ content. Given that there is no SOCE in normal rat ventricular myocytes, the mechanism of action of STIM1 in heart is, in effect, like that of revving up SERCA2a (see discussion below) and similar to knocking down PLN. The level of STIM1 expression thus appears to "set" the background SERCA Ca 2+ pump rate, with the moment-to-moment rate regulated by PLN phosphorylation. These provocative observations raise questions that focus our attention on what STIM1 may do when it does not produce SOCE.
PLN and SERCA2a. PLN is one of the primary regulators of SERCA2a (27) . When PLN binds to SERCA2a, it inhibits the Ca 2+ pumping function and thus reduces the ability of the SR to acquire and store Ca 2+ . The affinity of PLN for SERCA2a decreases when it is phosphorylated by PKA or Ca
2+
-calmodulin-dependent protein kinase. As PLN is converted into p-PLN, SERCA2a is disinhibited (i.e., activated). In addition to PLN, there are other modulators of SERCA2a (27) . The mechanism by which STIM1 interacts with SERCA2a (i.e., by binding the un-p-PLN) to indirectly activate SERCA2a is thus consistent with the sweep of other SERCA2a regulatory factors. SR Ca 2+ Leak. STIM1 overexpression also increases SR Ca 2+ leak. However, there is no evidence to date that it does this by interacting directly with the SR Ca 2+ release channel, the ryanodine receptor. Instead, we speculate that the increase in [Ca 2+ ] SR due to the indirect activation of SERCA2a by STIM1 leads to enhanced SR Ca 2+ efflux due to the luminal dependence of the ryanodine receptor on [Ca 2+ ] SR (36, 37) and also by mass action. The higher the [Ca 2+ ] SR , the higher the SR Ca 2+ leak flux when RyR2s are open.
What Does the Continuing Presence of STIM1 Puncta Mean in Cardiac
Ventricular Myocytes? That STIM1 forms puncta in cardiac jSR without requiring low [Ca 2+ ] SR/ER suggests that its function does not depend on a dynamic and active clustering of STIM1 proteins. Perhaps the interaction of STIM1 with PLN alone is sufficient to induce the clustering. If true, it does raise the speculation that the abundance of STIM1 per se may be the mechanism by which STIM1 influences Ca 2+ in cardiac SR. This would suggest that the Ca 2+ -sensing EF hand motif in STIM1 does not control the behavior of STIM1 or its function in heart. Instead, the STIM1 function would appear to depend on its ability to stimulate SERCA by "tying up" PLN and thereby disinhibiting SERCA. This is consistent with the physiological observations presented here in Fig. 5 and those made by Hulot and Luo, who show that expression of STIM1 goes up in pressure overload hypertrophy (8, 13) . Nevertheless, additional experiments are needed to better understand how STIM1 overexpression leads to elevated [Ca 2+ ] SR .
STIM1 and Its Protein Partners. The discovery and characterization of SOCE in nonexcitable cells revealed an important partnership between STIM1 and Orai1 with separate [Ca 2+ ] SR/ER sensing (STIM1) and separate Ca 2+ channel (Orai1) responsibilities. That a similar system occurs in many cell types including skeletal muscle has informed our investigation in the heart. In skeletal muscle, both Orai1 and STIM1 are found to be involved in SOCE (38) (39) (40) . However, during development in skeletal muscle, there appears to be a reciprocal relationship between SOCE and the presence of a PLN-like SERCA1a modulator, sarcolipin (SLN). As SOCE increases during skeletal muscle development, SLN decreases (41). Thus, the high level of PLN and absence of Orai1 and SOCE in adult heart echoes the protein and functional relationships in skeletal muscle. In adult heart, we found no consistent clear evidence that Orai1 is present, whereas there is some evidence for Orai1 and SOCE during development (12) . As noted earlier, the absence of Orai1 and SOCE did not surprise us, as huge Ca 2+ entry occurs with each heartbeat in the adult ventricular myocyte. The function served by STIM1, based on our work, suggests that it can bind to PLN, the cardiac modulator of SERCA2a, and possibly tune the SERCA2a function by disinhibiting it. In Fig. 8 B and E, we observed that SR Ca 2+ depletion by Tg enhances STIM1-PLN binding. We do not have a definitive explanation for this observation, but it could arise if the relative amount of free PLN were to increase due to the Tg treatment. An increase in the amount of unbound PLN could occur if the binding of Tg to SERCA (which inhibits its function) were also to decrease the binding affinity of PLN for SERCA, as recently suggested (42) . If so, the increased availability of PLN (from the PLN freed from the SERCA) would then increase the amount of PLN bound to STIM1. In contrast, the activation of PKA by isoproterenol (0.1 and 1 μM) stimulation decreases the binding of STIM1-PLN presumably by changes in PLN following its phosphorylation (i.e., p-PLN). These two observations suggest that STIM1 does not readily bind to p-PLN (SI Appendix, Fig. S10 ). As a consequence, STIM1 competes with SERCA2a for binding to PLN. These suggestions are consistent with our observations that STIM1 overexpression activates SERCA2a, presumably by mass action, and the more STIM1 there is, the more SERCA2a is disinhibited by the reduction of PLN bound to it. If true, STIM1 trafficking and expression may work as a "long-term" regulatory mechanism serving to modulate [Ca 2+ ] SR/ER .
Physiological Versus Pathophysiological Ca
2+ Signaling in the Heart and STIM1. The absence of SOCE and I SOCE in healthy heart cells is clearly demonstrated in our article. Nevertheless, in studies of dedifferentiated or pathological cardiac myocytes and studies of cells in long-term culture, there is support for the presence of Orai1 (or the equivalent). Because Orai1 is not detectable in adult ventricular myocytes by us and it is a necessary component of SOCE, our findings of the absence of SOCE and Orai1 are consistent. However, SOCE may be present during development or during the time when a cardiac pathology produces Orai1 (12 2+ selectivity has not been identified in normal adult ventricular myocytes. However, in a study of pressure overload cardiac hypertrophy, evidence was presented for the development of a nonselective cation channel (8) whose reversal potential is far negative to E Ca . This nonselective cation channel could be a member of the TRPC channel family, as suggested by some studies in cardiac myocytes (10, (43) (44) (45) .
SOCE has been suggested to play an essential role in early heart development. This finding is supported by the expression of both STIM1 and Orai1 early in development that declines with increasing maturity (13) . Thus, it seems reasonable to suggest that SOCE may exist in early development, yet more work is needed to characterize the magnitude of I SOCE and its function (s) and to account for its roles in developmental physiology and biology. Our work here in adult rat heart shows low expression of STIM1 and the absence of Orai1. The question is thus raised about what STIM1 may be doing in adult ventricular myocytes under physiological conditions. A clue comes from our discovery that elevated expression of STIM1 in 2-day primary cultures of adult ventricular myocytes leads to [Ca 2+ ] SR overload and the development of arrhythmogenic Ca 2+ waves. These findings suggest that STIM1 can regulate SR Ca 2+ content. The additional investigations here indicate that this regulation arises from a novel mechanism: STIM1 binds to un-p-PLN and, by this means, STIM1 increases SERCA2a-mediated Ca 2+ uptake into the SR. With the lower expression of STIM1 as seen under physiological conditions, these data suggest that STIM1 moderates SERCA2a-dependent [Ca 2+ ] SR . This function is probably important, as the long-term absence of STIM1 in cardiac-specific STIM1 knockout animals underlies serious disease (46) . These animals develop a progressive dilated cardiomyopathy starting around 20 wk of age and die prematurely starting around week 40 (46) . Although in young STIM1 cardiacspecific knockout mice there is no significant dysfunction, ER/ SR stress increases in these animals starting around 12 wk (46) . It is thus plausible that this ER/SR stress might arise from the decreases in SR Ca 2+ content (a common marker of ER/SR stress) (47) due to the mechanisms presented here. STIM1 may thus play an important and novel role in ventricular myocytes under physiological conditions by regulating [Ca 2+ ] SR and hence the [Ca 2+ ] i transient and contraction.
Materials and Methods
Cell Preparation and Transfection. Male Sprague-Dawley rats were anesthetized by a lethal i.p. injection of pentobarbital sodium. Ventricular myocytes were isolated as previously described (48), and the freshly isolated ventricular myocytes were used within 6 h of isolation or in short-term primary culture [M-199 medium supplemented with 0.1% ITS (insulin-transferrinselenium) and 10 μM blebbistatin]. The cultured cells were used to examine overexpression of STIM1-mCherry or STIM1-eYFP using an adenovirus construct or mCherry alone as a control. Experiments were performed 48 h after transfection with an MOI (multiplicity of infection) of 50 or 100 for STIM1-mCherry, STIM1-eYFP, or mCherry alone. The transfection efficiency is >∼80%.
For the imaging experiments, the measurements were restricted to those showing mCherry and eYFP fluorescence. For the co-IP and Western blot (including BN-PAGE), the cells were transfected with 50 or 100 MOI, and the fluorescence was not examined.
Clones and Construction of STIM1-mCherry and STIM1-eYFP Adenovirus. A rat STIM1 plasmid was the kind gift of Shenyuan Zhang (Texas A&M University, College Station, TX) (4). We fused STIM1 to the fluorescent protein mCherry following the modification of STIM1c to remove the stop codon and incorporating a Not I site at the 3′ end using PCR. mCherry was then fused in frame to the STIM1c by PCR using primers containing Not I and Xho I sites at the 5′ and 3′ ends, respectively. The STIM1 fusion construct was ligated into pShuttle CMV (Agilent Tech Inc.) using the Not I and Xho I sites in the vector. An adenovirus expressing the STIM1 fusion protein was produced according to the manufacturer's protocol and purified by banding through a CsCl density gradient (49) . Human STIM1-eYFP adenovirus was provided by Vector BioLabs.
Co-IP. Freshly isolated or short-term cultured (48 h) rat ventricular myocytes were placed in ice-cold lysis buffer [in mM, 150 NaCl, 25 Tris, 1 EDTA, 1% Nonidet P-40, and 5% (vol/vol) glycerol at pH 7.4, supplemented with 1% protease inhibitor mixture] (Sigma-Aldrich). After centrifugation at 10,000 × g for 10 min, the supernatant was collected and the amount of protein was measured. Co-IP experiments were performed as previously described (50) . In brief, 1-5 μg of the relevant antibody (anti-PLN, Abcam; anti-STIM1, Sigma-Aldrich; anti-mCherry, Abcam) was incubated with 50 μL of coupling resin or control agarose resin in a coupling buffer (10 mM sodium phosphate, 150 mM NaCl, pH 7.2) for 2 h at room temperature. The same amount of polyclonal (Alomone Laboratories) or monoclonal (NeuroMab, University of California, Davis/NIH) antibody to the BK channel (large conductance Ca 2+ -activated K + channel) α subunit was incubated with coupling resin and used as a negative control. The antibody-resin buffer mixture was then centrifuged and washed three times with coupling buffer and one time with quenching buffer (1 M Tris•HCl). Protein lysate (500 μg to 1 mg) was added to the antibody-resin pellet and shaken overnight at 4°C and then washed using the lysis buffer until the supernatant was protein-free. The antigen was eluted with a low pH elution buffer containing primary amines provided in the kit (Pierce Biotech). The protein was then separated and probed following a routine Western blot protocol described previously (50, 51) . The HRP/chemiluminescence signal was detected using ImageQuant LAS 4000 (GE Healthcare Biosciences). Quantitative analysis was carried out using the digital image output from the LAS 4000 and ImageJ software (NIH), with the background subtracted. For quantification of co-IP results, the band intensity was first normalized to its untreated control and then to the immunoprecipitated control. Statistics were performed only for those for which more than three independent tests have been carried out. Otherwise, only representative results were shown. Second-Dimensional SDS/PAGE and Western Blotting. For second-dimensional SDS/PAGE, a 4-20% one-well gel was used. Gel strips derived from the firstdimensional BN-PAGE were equilibrated in Tris-Glycine SDS sample buffer (Life Tech.) supplemented with 5% β-mercaptoethanol for 30 min at 37°C. The strip was then placed onto the second-dimensional gel for electrophoresis. For Western blotting, proteins were extracted from cells or tissues using either a RIPA (radio-immunoprecipitation assay) lysis buffer (SigmaAldrich) or a SDS Tris-Glycine SDS buffer. The following antibodies were used in the blotting: anti-STIM1 (Sigma, 1:1,000), anti-SERCA2a (Thermo or Santa Cruz, 1:500), anti-YFP (abm, 1:1,000), anti-mCherry (Abcam, 1:2,000), and anti-PLN (Abcam, 1:2,000). For quantitative purposes, GAPDH was reprobed in some of the membranes. Relative protein level was quantified using ImageJ 1.44p software (NIH), with background subtracted.
Immunochemistry. Freshly isolated adult rat ventricular myocytes were fixed using 3.7% paraformaldehyde in PBS for 15 min. After three washes with PBS, cells were permeabilized and blocked in PBS containing 5% goat serum and 0.3% triton X-100 for 1 h. Cells were then incubated overnight at 4°C with primary antibodies: polyclonal anti-STIM1, or mouse monoclonal anti-α-actinin, at a dilution of 1:100 (anti-STIM1) or 1:1,000 (anti-α-actinin) in PBS containing 0.5% BSA and 0.3% triton X-100. After three washes in PBS, cells were then incubated for 1 h at room temperature with secondary antibodies: Alexa Fluor 488-conjugated goat anti-mouse for α-actinin and Alexa Fluor 633-conjugated goat anti-rabbit for STIM1. Fluorescence images were acquired using a Zeiss LSM-510 laser scanning confocal microscopy. Alexa Fluor 488 and 633 were excited at 488 and 633 nm and emissions collected at 505-550 and >650 nm, respectively. Negative controls were prepared by omitting primary antibodies.
T7 Phage Display Screen and ELISA. Biotin-labeled STIM1c (238-685 aa) was expressed in sf9 cells and affinity-purified by Neutravidin column (Pierce). Purified STIM1c protein was then immobilized to avidin-coated 96-well plates and incubated with a T7 phage display peptide library (at a titer of 5.7 × 10 8 pfu per well) for 1 h at room temperature. The biopanning procedures were performed as directed (Novagen T7Select System). After three rounds of biopanning, the pool of enriched STIM1c-interacting phages were plated on LB plates, and single plaques were selected and amplified for individual ELISA to further verify STIM1c interaction. Specifically, individual phages (0.1 mL, 10 8 pfu/mL) were added into the STIM1c-coated wells and incubated for 2 h followed by five washes with PBS-T. Then anti-T7 phage antibody (Novagen) was added at a dilution of 1:2,000 and incubated for 1 h at room temperature. After washing, HRP-conjugated secondary antibody (1:5,000) was added and incubated for 1 h at room temperature. After five washes and a 30-min incubation in ABTS (2,2′-Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt, 0.1 mL per well) with 0.05% H 2 O 2 at room temperature, the plate was read at 405 nm with a plate reader. Only those phages that show notable ELISA signal to STIM1c (twofold over milk) were selected for PCR amplification with T7Select up and T7Select down primers (Novagen). The PCR products were purified and sequenced. STIM1c interacting proteins were deduced from the sequencing results and NCBI database blasting (Fig. 7F) .
Preabsorption of Anti-STIM1. To minimize the nonspecific staining by the anti-STIM1 antibody, the antibody was preabsorbed using STIM1-null (STIM1 −/− ) mouse ventricular myocytes. Briefly, anti-STIM1 antibody (diluted 1:5 in PBS containing 5% goat serum) was first incubated with permeabilized ventricular myocytes from a mouse (STIM1 −/− ) for 2 h at room temperature. The cells were then centrifuged at 1,000 × g for 5 min, and the supernatant (containing the anti-STIM1 antibody) was collected and used as a primary antibody for the immunostaining of STIM1 protein in rat ventricular myocytes. FRAP. A 6 × 6 μm area (avoiding the nucleus) was used for the photobleaching experiments using high illumination intensity (488 nm and 543 nm laser) in STIM1-mCherry-infected rat ventricular myocytes after 48 h in primary culture. The fluorescence recovery in the bleached area was monitored at 2 s per frame. The intensity ratio of the fluorescence was calculated from the ratio of the intensities of the bleached area and another region (3-5 μm apart from the bleached region). The ratio derived from the image before photobleaching was set to 1, and the ratio immediately after photobleaching was set to 0. Diffusion coefficients were calculated using ImageJ (1.44p) plugin software SimFRAP, based on the two-dimensional diffusion formulation: d = ffiffiffiffiffiffiffiffi ffi 4Dt p , where d is the distance (μm), D is the diffusion coefficient (μm 2 /s), and t is the time (s).
Reagents, Data Analysis, and Statistics. Unless otherwise specified, all reagents were purchased from Sigma-Aldrich. Data are presented as mean ± SEM. All data statistics are conducted using OriginPro 8.5.0. Where appropriate, Student's t test or ANOVA was used to test for significance. P values less than 0.05 are considered significant.
